**Question:** Treatment of choice for Bilateral retinoblastoma

**Core Concept:**
Retinoblastoma is a rare form of pediatric eye cancer that primarily affects infants and young children. It develops from the retinal cells and can be unilateral (one eye) or bilateral (both eyes). Bilateral retinoblastoma is more challenging to manage due to increased complexity and potential risks. Treatment options involve a combination of chemotherapy, radiation therapy, and enucleation (removal of the affected eye).

**Why the Correct Answer is Right:**
The correct answer (not mentioned in the options provided) refers to the principle of "Enucleation (removal of the affected eye) + Chemotherapy + Radiation Therapy" as the standard treatment for bilateral retinoblastoma. This approach aims to eliminate the cancer cells while minimizing damage to the healthy eye and general health.

**Why Each Wrong Option is Incorrect:**
A. Enucleation is essential in removing the affected eye and reducing the risk of cancer spreading to other parts of the body. However, it is not the primary treatment for bilateral retinoblastoma.
B. Chemotherapy alone is insufficient in treating bilateral retinoblastoma, as it does not address the cancer in the other eye.
C. Radiation therapy alone has significant risks, including visual impairment and cataracts, which outweigh its benefits in bilateral retinoblastoma cases.
D. Combining chemotherapy and radiation therapy is not sufficient for bilateral retinoblastoma, as it does not eliminate cancer cells in both eyes and increases the risk of systemic complications.

**Clinical Pearl:**
When managing bilateral retinoblastoma, a combination of enucleation, chemotherapy, and radiation therapy is essential to ensure effective treatment of both eyes while minimizing systemic risks and preserving the healthy eye. This multidisciplinary approach involves ophthalmologists, oncologists, and radiation oncologists to provide the best possible outcome for the patient.